164 related articles for article (PubMed ID: 7012631)
1. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.
Nobre G; Sobral T; Ferreira AF
Mycopathologia; 1981 Jan; 73(1):39-41. PubMed ID: 7012631
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of 5-fluorocytosine against Candida and Torulopsis species.
Shadomy S; Kirchoff CB; Ingroff AE
Antimicrob Agents Chemother; 1973 Jan; 3(1):9-14. PubMed ID: 4799552
[TBL] [Abstract][Full Text] [Related]
3. The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine.
Hamra LK; Pankiewicz IJ
Med J Aust; 1977 Nov; 2(22):749-50. PubMed ID: 347230
[TBL] [Abstract][Full Text] [Related]
4. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
Slim A; Bergogne-Berezin E; Courtoux D
Ann Biol Clin (Paris); 1978; 36(2):69-74. PubMed ID: 358866
[TBL] [Abstract][Full Text] [Related]
5. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
Utz CJ; Shadomy S
J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
[TBL] [Abstract][Full Text] [Related]
6. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
[TBL] [Abstract][Full Text] [Related]
7. In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.
Normark S; Schönebeck J
Antimicrob Agents Chemother; 1972 Sep; 2(3):114-21. PubMed ID: 4597703
[TBL] [Abstract][Full Text] [Related]
8. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
Ellis NS; Bartlett MS; Smith JW
Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
[TBL] [Abstract][Full Text] [Related]
9. In vitro development of resistance to nystatin by Candida albicans and Torulopsis glabrata.
Nobre GN; Pereira A; Coias R; Cordeiro J
J Gen Microbiol; 1980 May; 118(1):263-5. PubMed ID: 6999124
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
[TBL] [Abstract][Full Text] [Related]
11. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
Torres-Rodríguez JM; Sabaté M; Gallach C; Carrillo A; Madrenys N
Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Martín E; Parras P; Lozano MC
Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
[TBL] [Abstract][Full Text] [Related]
13. [Concentration-contact time relationship in the effect of antimycotic drug combinations (clotrimazole, nystatin, 5-fluorocytosine) and the effect of increasing and decreasing antimycotic drug concentrations on Candida albicans].
Rumler W; Heins S
Mykosen; 1985 May; 28(5):251-7. PubMed ID: 3892290
[No Abstract] [Full Text] [Related]
14. Synergism of amphotericin B and 5-fluorocytosine for candida species.
Montgomerie JZ; Edwards JE; Guze LB
J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
[TBL] [Abstract][Full Text] [Related]
15. [Sensitivity of Candida strains to selected antifungal antibiotics].
Jurek M; Dzierzanowska D
Pol Tyg Lek; 1984 Sep; 39(38):1269-71. PubMed ID: 6390387
[No Abstract] [Full Text] [Related]
16. Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections.
Segal E; Romano A; Eylan E; Stein R
Chemotherapy; 1975; 21(6):358-66. PubMed ID: 1183243
[TBL] [Abstract][Full Text] [Related]
17. In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis.
Mallié M; Montès B; Lebecq JC; Bastide JM
Mycoses; 1989 Dec; 32(12):631-7. PubMed ID: 2695841
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
Morace G; Manzara S; Dettori G
Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B.
Beggs WH; Sarosi GA; Steele NM
Antimicrob Agents Chemother; 1976 Jun; 9(6):863-5. PubMed ID: 779631
[TBL] [Abstract][Full Text] [Related]
20. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
